Introduction
The conjectured importance of zoonoses has prompted the scientific community and decision-makers to look for holistic initiatives that incorporate the health and ecosystem sectors in order to improve our understanding of complex health relationships and to reduce national and global health risks. One Health recognises that the health of humans, animals and ecosystems is connected and advocates coordinated, collaborative, interdisciplinary and cross-sectoral approaches. A harmonised and integrated approach -One Health -to mitigate health risks is appealing.
However, worldwide recognition of One Health approaches for more effective protection of the global community from health threats has not led to the systematic allocation of resources for integrated disease mitigation programmes. The authors argue that, in part, this is due to a lack of studies which assess the economic efficiency of One Health approaches and therefore the business case for such a change has been poorly substantiated. While costs for One Health initiatives are easier to document, there is a lack of standardised and established methods to measure the benefits of integrated programmes.
Definitions
Several definitions of One Health have been presented since the term 'One Medicine' was considered inadequate, because it did not reflect the interactions between human and animal health that reach beyond individual clinical issues (1) , and there is continuing debate about what constitutes One Health. In the past, it was mainly related to the interdependence of animal and human health, with the addition of environmental health. More recent definitions expand this to include other aspects that have an impact upon health and well-being; in particular, food security and poverty. For example, the Food and Agriculture Organization of the United Nations (FAO) sees One Health as 'a holistic vision to address complex challenges that threaten human and animal health, food security, poverty and the environments where diseases flourish' (2) . Another definition of One Health perceives it as adding value through closer cooperation among professionals: 'added value in terms of human and animal health, financial savings or social and environmental benefits from closer cooperation of professionals in the health, animal and environment sectors at all levels of organisation' (3) . The European Union (EU) uses a definition of One Health that refers to health hazards: 'the improvement of health and wellbeing through: a) the prevention of risks and the mitigation of effects of crises that originate at the interface between humans, animals and their various environments, and b) promoting a cross-sectoral, collaborative, "whole of society" approach to health hazards, as a systemic change of perspective in the management of risks'. In a similar way to the previous definition, it implies that One Health has a value, i.e. it refers to the 'improvement' of health and wellbeing in comparison to a status quo (which is most likely a non-integrated, uni-sectoral or uni-disciplinary approach). Other definitions do not refer to added value, but rather describe the concept. For example, the American Veterinary Medical Association defines One Health as 'the integrative effort of multiple disciplines working locally, nationally, and globally to attain optimal health for people, animals, and the environment' (4). As a working definition for the purpose of this paper, the authors suggest the following broad definition, based on Miller et al. (5) : 'One Health is a concept that addresses complex challenges to promote the health and well-being of all species through the integration of relevant sciences at the systems level.'
The problem
During the last five years, there has been a growing momentum, particularly from the international community, to request that health research, systems and services implement a One Health approach (6) . Several projects and activities have been developed and are now working within this concept at the national, regional and global level (7), based on the expectation that a more holistic management of microbial health hazards will result in a more efficient use of the scarce resources available for mitigating zoonotic disease risk.
However, such a paradigm shift has not been supported by the systematic allocation of resources to integrated national or multinational programmes. At the national level, Ministries of Health and Agriculture (or Animal Health) remain largely separate, with individual budgets and agendas (6) . This is partly due to a lack of convincing economic arguments in support of the One Health approach; the inertia of existing sectoral systems (6); barriers to information-sharing and reporting within and across institutions (8); a lack of agreement on leadership issues, resource allocation and task distribution among partners (9, 10); and insufficient indicators and measures of health (11). There has also been a dearth of studies to estimate the costs of such a change. Examples in which efficiency gains and the generation of net benefits to society have been demonstrated are mainly single projects or small-scale modifications of health systems, because no country has taken a decision towards major funding of institutions whose main activity is One Health (6) . To further the One Health cause and promote its adoption globally, studies demonstrating the added value of One Health (in comparison to disciplinary, uni-sectoral or non-integrated) approaches are needed (12) . Another challenge is that One Health initiatives have a strong disease focus, but often fail to address ecosystem components, malnutrition (both under-and over-nutrition), or poverty (12) .
Some economic evidence for One Health benefits exists. In particular, this evidence involves cost savings and risk mitigation programmes for endemic zoonotic diseases, in which a strategic greater allocation of budgetary and other resources provides sufficient financing to control disease along the livestock value chain, leading to benefits in humans (6, 13, 14, 15) . However, there is very sparse evidence about the economic efficiency of One Health surveillance systems, analysed either as independent strategies or incrementally; or about the prevention of disease emergence (6) . Economic analyses of One Health benefits from strategies to reduce poverty or address malnutrition are hard to find.
The authors argue that the problem of limited and partial economic evidence on One Health lies in the absence of standardised methods to fully capture the complexity of the benefits gained from a more holistic health approach. This is largely due to a disconnection between disciplines in the past, resulting in specific disciplinary metrics that fail to appreciate other disciplines. To date, health impact assessments, environmental impact assessments, agricultural impact evaluations and socio-economic impact analyses have been performed. While some overlap exists across these approaches, there is no systematic methodology to reflect the intertwined nature of health impacts across the animal and human health sectors, the environment and agriculture. For example, in agriculture and animal husbandry, productivity is commonly used as a measure. Databases such as the Global Livestock Impact Mapping System, hosted by FAO, provide background data on biophysical, livestock population and production, socioeconomic, animal health and trade parameters, but do not explicitly link productivity losses to disease incidence or human health impacts. Similar problems are seen in the field of human health, in which Disability-Adjusted Life Years are used to rank disease impacts, but do not take into account impacts on livestock production, health and welfare, or the impact of a zoonotic disease on livestock or the results of the threat of its emergence on people' s livelihoods or wider societal aspects, related to constraints in livestock sector development and food supply. Disability-Adjusted Life Years also provide no information on expenditure caused by the presence or risk of disease or the lost opportunities in markets or the use of sub-optimal technologies in food systems (compared with animal disease impact assessments). This disciplinary isolation constrains the development of integrated data collection protocols and databases, and limits information on the priority of problems to be tackled and potential intervention points.
Consequently, there is a lack of combined metrics in complex systems that allow us to assess the benefits of One Health initiatives in terms of their health (human and animal), economic, social, biological, environmental and cultural benefits. The development of such metrics is not only a prerequisite for assessing whether One Health adds value compared to traditional approaches, but also provides an important tool to assess the impact of multiple ongoing One Health initiatives at various levels.
Aim
One Health promotes integrative health risk management at the systems level to provide a comprehensive, strategic approach to future health challenges. Current impact assessments do not cover the continuum of human through to animal health problems, and those that attempt it are often led by prioritisation processes dominated by expert opinion. This too often results in a stubborn institutionalisation of programmes and the preferential treatment of certain types of health problems. Questions need to be posed, therefore, about how we can estimate the benefits of One Health in a standardised way to provide the economic evidence that decision-makers need to allocate their resources effectively (16) .
Commonly mentioned benefits of One Health to mitigate zoonotic disease risks include:
-increasing the benefit gained per resource unit used, by sharing resources in the field -more accurate measurement of societal benefits through the integrated valuation of the impact of disease mitigation on human and animal health -a reduction in the likelihood of zoonotic disease emergence and establishment -a reduction in uncertainty in disease mitigation decisions -improved information, data, knowledge and collaboration.
The long-term aim of the authors is to develop a framework that explicitly incorporates the heterogeneity of One Health and allows the measurement of all dimensions of One Health benefits in a standardised and consistent way, allowing for adequate comparisons and even meta-analyses in the future. As a first step towards this aim, a review of the literature has been conducted to identify the metrics and associated methods presented so far in the scientific literature for assessing the benefits of One Health activities.
Methodology
The authors conducted a review of the scientific and grey literature to create an inventory of One Health benefits and the metrics used to measure those benefits. For the scientific literature search, they used Scopus, PubMed and Web of Science, using a title and abstract search, without any restrictions in terms of language, year, or similar. . All references were extracted into a Mendeley reference manager and screened independently by two researchers, using primary exclusion criteria. When no abstract was available, the title was used to take a decision for inclusion or exclusion. The exclusion criteria were:
-the reference did not refer to Ecohealth or One Health as a concept, and -the reference did not refer to any kind of benefit or value.
No secondary screening was considered necessary and all the articles were downloaded for a full text review and the extraction of information of interest. The same search terms were used in Google, where result pages were screened for relevant publications of any type (e.g. web presentations, reports, peer-reviewed publications) until three subsequent pages did not produce any further relevant results. These publications were added to the list of papers for full text review. Any other relevant publications found while reading the full text were added to the review. In addition to the publication details, the following information (where applicable) was extracted in the full text review: -the output (e.g. intervention, programme, database, collaboration, etc.) -the benefits: type of benefit (free text), plus categorisation into economic, social, environmental, human health, animal health, or other benefit -the type of article: conceptual, applied or other -was a metric used to measure benefits? yes/no -if a metric was used, what was/were the: study objective, method/technique, target groups, data used, software, limitations, advantages?
Results
In Scopus, 513 articles were found; 411 were found in PubMed and 80 in Web of Science (379 were duplicates, which resulted in a total of 625 articles for the primary screening). Of these, 111 were kept for the full text screening. Thirty-three additional publications were added from the Google search and ten from the full text review.
One Health benefits
The various One Health benefits described in the publications reviewed are presented in Table I . Economic, social, technical, animal and human health, environmental and information benefits are listed. The majority of benefits fell into the groups of more effective disease control and/ or biosecurity measures (often related to infectious disease) and improvements in both animal and human health and well-being, as well as economic benefits.
These benefits range from rather specific measures, focusing on one type of output (e.g. a 15% reduction in costs), to all-inclusive expected benefits, referring to one or more hazards that could be disaggregated into their respective outcomes (e.g. preventing, detecting and combating future pandemics of H1N1) and very broad aspects that are difficult to disaggregate (e.g. ecosystem resilience). Also, many of the benefits described are intermediaries (e.g. improved coordination, knowledge, skills, capacity, and management) that contribute to the final benefits of improved health or economic efficiency.
Metrics and associated methods used
In the majority of studies, the expected or perceived benefits stemming from One Health were listed in a descriptive or conceptual way, and only a small number of studies reported a benefit that was 'measured', either in monetary or nonmonetary terms. These exceptions are listed in Table II . Early detection of threat and timely, effective or rapid response, e.g.
-using pets as sentinels (e.g. to detect lead poisoning)
-the use of mobile technology for integrated data collection The benefits described largely refer to technical intermediary outputs without describing the final outcome, which would, for example, be less mortality or morbidity, higher productivity, etc. Higher quality or larger quantity of information and data and improved knowledge or skills, e.g. 
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Ecosystem benefit, e.g. 
Discussion
The problem of limited and partial evidence on the added value of One Health identified by the present study was not solved through a systematic review of information on One Health and its benefits. The authors recognise that this may, in part, be related to the way in which the search was carried out. In particular, by explicitly searching for the terms 'One Health' or 'Ecohealth', some initiatives that would fall under the One Health definition, but were not labelled as such, would have been missed, and, in turn, any measurements of the benefits of such activities. Nevertheless, previous (non-systematic) reviews reporting on the economics of One Health have failed to identify additional studies. Consequently, there seems to be a real lack of studies reporting on the added value of One Health and its measurement.
While there seems to be a broad consensus about the value of One Health in the published studies, there is an evident lack of metrics and associated methods to estimate One Health benefits in a systematic way. There are slightly different needs in this regard. A large-scale change in the allocation of government resources needs clearly defined metrics on the costs of inputs to One Health and also measurable and comparable outcomes. This would require changes in the ways in which governments carry out data collection, as well as the use of econometric methods to define the productivity gains from such a major shift in policy.
At the grassroots level, the needs are different and only a few studies use a scientific approach to measure and demonstrate the value of One Health. However, there are no studies that use randomised control trials or a case-control study design to actively investigate whether there is, in fact, an added value resulting from One Health. From a strictly scientific point of view, such studies would be needed to generate the necessary evidence and basis for larger investments in One Health. This would require some element of comparison -as used, for example, in case-control study designs or modelling approaches that compare the scenario of interest with a counterfactual. Since many One Health initiatives are already under way, both large and small, relevant data collection protocols should be established now to enable us to make use of the data being generated during the change to a more comprehensive disease management approach.
Owing to their holistic nature, One Health activities can result in a wide range of benefits, spanning aspects from the social (e.g. empowerment, poverty reduction) to the economic (e.g. cost reduction, economic growth) and environmental (e.g. ecosystem resilience, wildlife conservation) to health (e.g. improved well-being and public health). From the literature review, five large categories of benefits crystallise:
-protection of the environment and healthier ecosystems -enhanced social and cultural values -improvements in human and animal health and wellbeing, and animal welfare -better/improved/more effective/more rapid disease control and/or biosecurity measures -a higher quality or quantity of information and data; more knowledge and better skills.
Consequently, metrics from many different disciplines are needed to measure the resulting outputs and/or outcomes. Disciplinary approaches and methods for measurement are manifold; a wide range of methods are used for economic impact assessment (e.g. cost-benefit analysis, economic surplus analysis, mathematical programming, general or partial equilibrium models); economic evaluation of health and healthcare economics (e.g. costs of illness, cost-minimisation analysis, cost-effectiveness analysis, cost-utility analysis, cost-benefit analysis); or to value ecosystem services (e.g. market-price method, productivity Consequently, the key task does not seem to focus on the development of new metrics, but rather on finding ways of integrating the established disciplinary metrics that are standardised and commonly used, as well as on combining qualitative and quantitative data sets. Only with a standardised approach that has been accepted and applied by the scientific community can the necessary evidence base be generated to assess the real value of One Health.
In summary, three key challenges follow from the above considerations, which need to be urgently addressed by the scientific community:
-the development of protocols to capture ongoing change -the integration of available disciplinary metrics -data collection that captures One Health inputs and outcomes.
To address the scarcity of metrics and associated methods to estimate the One Health benefits identified in the literature review, as well as the shortcomings described above, the authors organised a workshop of international experts in public health and zoonotic diseases, as well as economists who work on health issues. The findings of this workshop, which was held in London in September 2013, focus on how frameworks to capture benefits can be developed and applied; a summary of the discussions is available online (http://www.lcirah.ac.uk/node/141). There is an urgent need for such work in the development of a One Health business case. Therefore, the authors and colleagues are establishing an international, interdisciplinary Network for Evaluation of One Health (NEOH) that aims to enable future quantitative evaluations of One Health activities, and to further the evidence base by developing and applying a science-based evaluation protocol in a community of experts (further information available from the authors on request). 
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